The X chromosome in immune functions: When a chromosome makes the difference

Nature Reviews Immunology

Volumn 10, Issue 8, 2010, Pages 594-604

  Libert, Claude ^a,b   Dejager, Lien ^a,b   Pinheiro, Iris ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; SEX HORMONE;

AUTOIMMUNITY; CHROMOSOME ABERRATION; GENE LOCATION; GENETIC SUSCEPTIBILITY; HOMOLOGOUS RECOMBINATION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOLOGICAL TOLERANCE; PRIORITY JOURNAL; REVIEW; SEX CHROMOSOME; X CHROMOSOME; X CHROMOSOME INACTIVATION; ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASE; COMMUNICABLE DISEASE; DISEASE PREDISPOSITION; FEMALE; GENETICS; MALE; SEX DIFFERENCE;

ADAPTIVE IMMUNITY; AUTOIMMUNE DISEASES; CHROMOSOMES, HUMAN, X; COMMUNICABLE DISEASES; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; MALE; SEX FACTORS;

EID: 77954948753     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2815     Document Type: Review

References (102)

1. Aspinall, R. Longevity and the immune response. Biogerontology 1, 273-278 (2000).
2. Choudhry, M. A., Bland, K. I. & Chaudry, I. H. Gender and susceptibility to sepsis following trauma. Endocr. Metab. Immune Disord. Drug Targets 6, 127-135 (2006).
3. Gannon, C. J., Pasquale, M., Tracy, J. K., McCarter, R. J. & Napolitano, L. M. Male gender is associated with increased risk for postinjury pneumonia. Shock 21, 410-414 (2004).
4. Butterworth, M., McClellan, B. & Aklansmith, M. Influence of sex on immunoglobulin levels. Nature 214, 1224-1225 (1967).
5. Purtilo, D. T. & Sullivan, J. L. Immunological bases for superior survival of females. Am. J. Dis. Child. 133, 1251-1253 (1979).
6. Burch, P. R. J. & Rowell, N. R. Genetic origin of some sex differences among human beings. Pediatrics 36, 658-659 (1965).
7. Migeon, B. R. Females are mosaics: X inactivation and sex differences in disease (Oxford University Press, New York, 2007).
8. Glezen, W. P. et al. Epidemiologic patterns of acute lower respiratory disease of children in a pediatric group practice. J. Pediatr. 78, 397-406 (1971).
9. Hall, C. B., Kopelman, A. E., Douglas, R. G., Geiman, J. M. & Meagher, M. P. Neonatal respiratory syncytial virus-infection. N. Engl. J. Med. 300, 393-396 (1979).
10. Kunin, C. M. Antibody distribution against non-enteropathic E. coli. Arch. Intern. Med. 110, 676-686 (1962).
11. Thompson, D. J., Gezon, H. M., Rogers, K. D., Yee, R. B. & Hatch, T. F. Excess risk of staphylococcal infection and disease in newborn males. Am. J. Epidemiol. 84, 314-328 (1966).
12. Strachan, N. J. C. et al. Sexual dimorphism in campylobacteriosis. Epidemiol. Infect. 136, 1492-1495 (2008).
13. Green, M. S. The male predominance in the incidence of infectious diseases in children: a postulated explanation for disparities in the literature. Int. J. Epidemiol. 21, 381-386 (1992).
14. Restif, O. & William, A. The evolution of sex-specific immune defenses. Proc. R. Soc. Lond. B Biol. Sci. Mar 24 2010 (doi:10.1098/rspb.2010. 0188).
15. Migeon, B. R. The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases. JAMA 295, 1428-1433 (2006).
16. Morris, J. A. & Harrison, L. M. Hypothesis: increased male mortality caused by infection is due to a decrease in heterozygous loci as a result of a single X chromosome. Med. Hypotheses 72, 322-324 (2009).
17. Spolarics, Z. The X-files of inflammation: cellular mosaicism of X-linked polymorphic genes and the female advantage in the host response to injury and infection. Shock 27, 597-604 (2007).
18. Arnold, A. P. Sex chromosomes and brain gender. Nature Rev. Neurosci. 5, 701-708 (2004).
19. Lleo, A., Battezzati, P. M., Selmi, C., Gershwin, M. E. & Podda, M. Is autoimmunity a matter of sex? Autoimmun. Rev. 7, 626-630 (2008).
20. Ozcelik, T. X chromosome inactivation and female predisposition to autoimmunity. Clin. Rev. Allergy Immunol. 34, 348-351 (2008).
21. Selmi, C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract. Res. Clin. Rheumatol. 22, 913-922 (2008).
22. Deitch, E. A. et al. Neutrophil activation is modulated by sex hormones after trauma-hemorrhagic shock and burn injuries. Am. J. Physiol. Heart Circ. Physiol. 291, 1456-1465 (2006).
23. Nalbandian, G. & Kovats, S. Understanding sex biases in immunity\effects of estrogen on the differentiation and function of antigen-presenting cells. Immunol. Res. 31, 91-106 (2005).
24. Szalay, L. et al. Androstenediol administration after trauma-hemorrhage attenuates inflammatory response, reduces organ damage, and improves survival following sepsis. Am. J. Physiol. Gastrointest. Liver Physiol. 291, 260-266 (2006).
25. Burgoyne, P. S. et al. The genetic basis of XX-XY differences present before gonadal sex differentiation in the mouse. Philos. Trans. R. Soc. Lond. B Biol. Sci. 350, 253-260 (1995).
26. Palaszynski, K. M. et al. A Yin-Yang effect between sex chromosome complement and sex hormones on the immune response. Endocrinology 146, 3280-3285 (2005).
27. Washburn, T. C., Medearis, D. N. & Childs, B. Sex differences in susceptibility to infections. Pediatrics 35, 57-64 (1965).
28. McMillen, M. M. Differential mortality by sex in fetal and neonatal deaths. Science 204, 89-91 (1979).
29. Forest, M. G., Cathiard, A. M. & Bertrand, J. A. Evidence of testicular activity in early infancy. J. Clin. Endocrinol. Metab. 37, 148-151 (1973).
30. Mage, D. T. & Donner, M. A genetic basis for the sudden infant death syndrome sex ratio. Med. Hypotheses 48, 137-142 (1997).
31. Morris, J. A. & Harrison, L. M. Sudden unexpected death in infancy: evidence of infection. Lancet 371, 1815-1816 (2008).
32. Weber, M. A. et al. Infection and sudden unexpected death in infancy: a systematic retrospective case review. Lancet 371, 1848-1853 (2008).
33. Notarangelo, L. et al. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee meeting in Budapest, 2005. J. Allergy Clin. Immunol. 117, 883-896 (2006).
34. Pessach, I. M. & Notarangelo, L. D. X-linked primary immunodeficiencies as a bridge to better understanding X-chromosome related autoimmunity. J. Autoimmun. 33, 17-24 (2009).
35. Teahan, C., Rowe, P., Parker, P., Totty, N. & Segal, A. W. The X-linked chronic granulomatous-disease gene codes for the β-chain of cytochrome-b-245. Nature 327, 720-721 (1987).
36. Bennett, C. et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nature Genet. 27, 20-21 (2001).
37. Noguchi, M. et al. Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73, 147-157 (1993)
38. Leonard, W. J. Cytokines and immunodeficiency diseases. Nature Rev. Immunol. 1, 200-208 (2001).
39. Mordmuller, B., Turrini, F., Long, H., Kremsner, P. G. & Arese, P. Neutrophils and monocytes from subjects with the Mediterranean G6PD variant: effect of Plasmodium falciparum hemozoin on G6PD activity, oxidative burst and cytokine production. Eur. Cytokine Netw. 9, 239-245 (1998).
40. Wilmanski, J., Siddiqi, M., Deitch, E. A. & Spolarics, Z. Augmented IL-10 production and redox-dependent signaling pathways in glucose-6-phosphate dehydrogenase-deficient mouse peritoneal macrophages. J. Leukoc. Biol. 78, 85-94 (2005).
41. Smahi, A. et al. Genomic rearrangement in NEMO impairs NF-κB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature 405, 466-472 (2000).
42. Uzel, G. The range of defects associated with nuclear factor κB essential modulator. Curr. Opin. Allergy Clin. Immunol. 5, 513-518 (2005).
43. Orange, J. S. et al. The presentation and natural history of immunodeficiency caused by nuclear factor κB essential modulator mutation. J. Allergy Clin. Immunol. 11 3, 725-733 (2004).
44. Orange, J. S. et al. Human nuclear factor κB essential modulator mutation can result in immunodeficiency without ectodermal dysplasia. J. Allergy Clin. Immunol. 11 4, 650-656 (2004).
45. Orange, J. S., Levy, O. & Geha, R. S. Human disease resulting from gene mutations that interfere with appropriate nuclear factor-κB activation. Immunol. R e v. 203, 21-37 (2005).
46. Vicoso, B. & Charlesworth, B. Evolution on the X chromosome: unusual patterns and processes. Nature Rev. Gen. 7, 645-653 (2006).
47. Ohno, S. Sex Chromosomes and Sex-Linked Genes (Springer, Berlin, 1967).
48. Nguyen, D. K. & Disteche, C. M. Dosage compensation of the active X chromosome in mammals. Nature Genet. 38, 47-53 (2006).
49. Vallender, E. J. & Lahn, B. T. How mammalian sex chromosomes acquired their peculiar gene content. Bioessays 26, 159-169 (2004).
50. Wang, P. J., McCarrey, J. R., Yang, F. & Page, D. C. An abundance of X-linked genes expressed in spermatogonia. Nature Genet. 27, 422-426 (2001).
51. Ross, M. T. et al. The DNA sequence of the human X chromosome. Nature 434, 325-337 (2005).
52. Carrel, L. & Willard, H. F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434, 400-404 (2005).
53. Johnston, C. M. et al. Large-scale population study of human cell lines indicates that dosage compensation is virtually complete. Plos Genet. 4, e9 (2008).
54. Wilson, M. A. & Makova, K. D. Evolution and survival on eutherian sex chromosomes. PLoS Genet. 5, e1000568 (2009).
55. Ditton, H. J., Zimmer, J., Rajpert-De Meyts, E. & Vogt, P. H. The AZFa gene DBY (DDX3Y) is widely transcribed but the protein is limited to the male germ cells by translation control. Hum. Mol. Genet. 13, 2333-2341 (2004).
56. Decker, T. et al. The TBK-1 substrate DDX3X, a DEAD-box RNA helicase, provides innate immunity to Listeria monocytogenes. Cytokine 43, 304 (2008).
57. Soulat, D. et al. The DEAD-box helicase DDX3X is a critical component of the TANK-binding kinase 1-dependent innate immune response. EMBO J. 27, 2135-2146 (2008).
58. Anderson, C. L. & Brown, C. J. Polymorphic X-chromosome inactivation of the human TIMP1 gene. Am. J. Hum. Genet. 65, 699-708 (1999).
59. Brown, C. J., Carrel, L. & Willard, H. F. Expression of genes from the human active and inactive X chromosomes. Am. J. Hum. Genet. 60, 1333-1343 (1997).
60. Vanlaere, I. & Libert, C. Matrix metalloproteinases as drug targets in infections caused by Gram-negative bacteria and in septic shock. Clin. Microbiol. Rev. 22, 224-239 (2009).
61. Hoffmann, U. et al. Matrix-metalloproteinases and their inhibitors are elevated in severe sepsis: prognostic value of TIMP-1 in severe sepsis. Scand. J. Infect. Dis. 38, 867-872 (2006).
62. Burkhardt, J. et al. Association of the X-chromosomal genes TIMP1 and IL9R with rheumatoid arthritis. J. Rheumatol. 36, 2149-2157 (2009).
63. Migeon, B. R. Why females are mosaics, X-chromosome inactivation, and sex differences in disease. Gend. Med. 4, 97-105 (2007).
64. Migeon, B. R. Non-random X chromosome inactivation in mammalian cells. Cytogenet. Cell Genet. 80, 142-148 (1998).
65. Orstavik, K. H. X chromosome inactivation in clinical practice. Hum. Genet. 126, 363-373 (2009).
66. Migeon, B. R. et al. Selection against lethal alleles in females heterozygous for incontinentia pigmenti. Am. J. Hum. Genet. 44, 100-106 (1989).
67. Fearon, E. R., Kohn, D. B., Winkelstein, J. A., Vogelstein, B. & Blaese, R. M. Carrier detection in the Wiskott Aldrich syndrome. Blood 72, 1735-1739 (1988).
68. Van den Bogaard, R. et al. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. Eur. J. Hum. Genet. 8, 513-518 (2000).
69. Gleicher, N. & Barad, D. H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 28, 1-6 (2007).
70. Jacobson, D. L., Gange, S. J., Rose, N. R. & Graham, N. M. H. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84, 223-243 (1997).
71. Kast, R. E. Hypothesis-predominance of autoimmune and rheumatic diseases in females. J. Rheumatol. 4, 288-292 (1977).
72. Stewart, J. J. The female X-inactivation mosaic in systemic lupus erythematosus. Immunol. Today 19, 352-357 (1998).
73. Takeno, M. et al. Autoreactive T cell clones from patients with systemic lupus erythematosus support polyclonal autoantibody production. J. Immunol. 158, 3529-3538 (1997).
74. Scofield, R. H. et al. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum. 58, 2511-2517 (2008).
75. Litsuka, Y. et al. Evidence of skewed X-chromosome inactivation in 47,XXY and 48,XXYY Klinefelter patients. Am. J. Med. Genet. 98, 25-31 (2001).
76. Brix, T. H. et al. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: A possible explanation for the female predisposition to thyroid autoimmunity. J. Clin. Endocrinol. Metab. 90, 5949-5953 (2005).
77. Ozbalkan, Z. et al. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum. 52, 1564-1570 (2005).
78. Ozcelik, T. et al. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur. J. Hum. Genet. 14, 791-797 (2006).
79. Uz, E. et al. Skewed X-chromosome inactivation in scleroderma. Clin. Rev. Allergy Immunol. 34, 352-355 (2008).
80. Invernizzi, P. The X chromosome in female-predominant autoimmune diseases. Ann. N Y Acad. Sci. 1110, 57-64 (2007).
81. Chitnis, S. et al. The role of X-chromosome inactivation in female predisposition to autoimmunity. Arthritis Res. 2, 399-406 (2000).
82. Lu, Q. et al. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179, 6352-6358 (2007).
83. Forsdyke, D. R. X chromosome reactivation perturbs intracellular self/not-self discrimination. Immunol. Cell Biol. 87, 525-528 (2009).
84. Zhou, Y. et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin. Immunol. 132, 362-370 (2009).
85. Subramanian, S. et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl Acad. Sci. USA 103, 9970-9975 (2006).
86. Smith-Bouvier, D. L. et al. A role for sex chromosome complement in the female bias in autoimmune disease. J. Exp. Med. 205, 1099-1108 (2008).
87. Invernizzi, P. et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol. 175, 575-578 (2005).
88. Ranke, M. B. & Saenger, P. Turner's syndrome. Lancet 358, 309-314 (2001).
89. Elsheikh, M., Wass, J. A. H. & Conway, G. S. Autoimmune thyroid syndrome in women with Turner's syndrome\the association with karyotype. Clin. Endocrinol. 55, 223-226 (2001).
90. Sybert, V. P. & McCauley, E. Turner's syndrome. N. Engl. J. Med. 351, 1227-1238 (2004).
91. Bondy, C. A. & Cheng, C. Monosomy for the X chromosome. Chromosome Res. 17, 649-658 (2009).
92. Invernizzi, P. et al. Frequency of monosomy X in women with primary biliary cirrhosis. Lancet 363, 533-535 (2004). (Pubitemid 38229455)
93. Baltimore, D. Our genome unveiled. Nature 409, 814-816 (2001).
94. Disteche, C. M. Escapees on the X chromosome. Proc. Natl Acad. Sci. USA 96, 14180-14182 (1999).
95. Disteche, C. M., Filippova, G. N. & Tsuchiya, K. D. Escape from X inactivation. Cytogenet. Genome Res. 99, 36-43 (2002).
96. Lewis, B. P., Burge, C. B. & Bartel, D. P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20 (2005).
97. Guo, X. J., Su, B., Zhou, Z. M. & Sha, J. H. Rapid evolution of mammalian X-linked testis microRNAs. BMC Genomics 10, 97(2009).
98. le Sage, C. et al. Regulation of the p27(Kip1) tumor suppressor by miR-221 and miR-222 promotes cancer cell proliferation. EMBO J. 26, 3699-3708 (2007).
99. Johnnidis, J. B. et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature 451, 1125-1129 (2008).
100. Fontana, L. et al. MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nature Cell Biol. 9, 775-787 (2007).
101. Rosa, A. et al. The interplay between the master transcription factor PU.1 and miR-424 regulates human monocyte/macrophage differentiation. Proc. Natl Acad. Sci. USA 104, 19849-19854 (2007).
102. Cooper, G. S. & Stroehla, B. C. The epidemiology of autoimmune diseases. Autoimmun. Rev. 2, 119-125 (2003).